Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea

Jong Hwa Yum, Sung Hak Choi, Dongeun Yong, Yunsop Chong, Weon Bin Im, Dong Kwon Rhee, Kyungwon Lee

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Resistance of Gram-positive pathogens to first-line antimicrobial agents has been increasing in many parts of the world. We compared the in vitro activities of torezolid with those of other antimicrobial agents, including linezolid, against clinical isolates of major aerobic and anaerobic bacteria. Torezolid had an MIC90 of ≤0.5 μg/ml for the Gram-positive bacterial isolates tested and was more potent than either linezolid or vancomycin.

Original languageEnglish
Pages (from-to)5381-5386
Number of pages6
JournalAntimicrobial agents and chemotherapy
Volume54
Issue number12
DOIs
Publication statusPublished - 2010 Dec

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea'. Together they form a unique fingerprint.

  • Cite this